These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 30051370)

  • 1. Increasing Breast Cancer Systemic Therapy Use Before Surgery in the United States: Scaling Down and the Promise of Selective Elimination of Surgery.
    Kuerer HM
    Ann Surg Oncol; 2018 Oct; 25(11):3115-3118. PubMed ID: 30051370
    [No Abstract]   [Full Text] [Related]  

  • 2. Preoperative therapy in invasive breast cancer: pathologic assessment and systemic therapy issues in operable disease.
    Gralow JR; Burstein HJ; Wood W; Hortobagyi GN; Gianni L; von Minckwitz G; Buzdar AU; Smith IE; Symmans WF; Singh B; Winer EP
    J Clin Oncol; 2008 Feb; 26(5):814-9. PubMed ID: 18258991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Omitting Surgery in Complete Responders After Neoadjuvant Chemotherapy: The Quest Continues.
    Mamounas EP
    Ann Surg Oncol; 2018 Oct; 25(11):3119-3122. PubMed ID: 30062473
    [No Abstract]   [Full Text] [Related]  

  • 4. [Neoadjuvant systemic therapy in breast cancer].
    Kahán Z; Nikolényi A; Uhercsák G; Thurzó L
    Orv Hetil; 2009 Jan; 150(2):65-71. PubMed ID: 19103557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical issues in patients with breast cancer receiving neoadjuvant chemotherapy.
    King TA; Morrow M
    Nat Rev Clin Oncol; 2015 Jun; 12(6):335-43. PubMed ID: 25850554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current and future role of neoadjuvant therapy for breast cancer.
    Untch M; Konecny GE; Paepke S; von Minckwitz G
    Breast; 2014 Oct; 23(5):526-37. PubMed ID: 25034931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reducing local therapy in patients responding to preoperative systemic therapy: are we outsmarting ourselves?
    Marks LB; Prosnitz LR
    J Clin Oncol; 2014 Feb; 32(6):491-3. PubMed ID: 24378409
    [No Abstract]   [Full Text] [Related]  

  • 8. Breast tattoos for planning surgery following neoadjuvant chemotherapy.
    Lannin DR; Grube B; Black DS; Ponn T
    Am J Surg; 2007 Oct; 194(4):518-20. PubMed ID: 17826070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative chemotherapy for breast cancer.
    Buzdar AU
    Clin Adv Hematol Oncol; 2004 Apr; 2(4):212, 215. PubMed ID: 16163183
    [No Abstract]   [Full Text] [Related]  

  • 10. Systemic treatment of early breast cancer--a biological perspective.
    Greenberg S; Stopeck A; Rugo HS
    J Surg Oncol; 2011 May; 103(6):619-26. PubMed ID: 21480257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. International expert panel on the use of primary (preoperative) systemic treatment of operable breast cancer: review and recommendations.
    Kaufmann M; von Minckwitz G; Smith R; Valero V; Gianni L; Eiermann W; Howell A; Costa SD; Beuzeboc P; Untch M; Blohmer JU; Sinn HP; Sittek R; Souchon R; Tulusan AH; Volm T; Senn HJ
    J Clin Oncol; 2003 Jul; 21(13):2600-8. PubMed ID: 12829681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast MRI for management of patients with locally advanced breast cancer who are being referred for neoadjuvant chemotherapy.
    Technol Eval Cent Assess Program Exec Summ; 2004 Sep; 19(7):1-4. PubMed ID: 15724315
    [No Abstract]   [Full Text] [Related]  

  • 13. Neoadjuvant versus adjuvant systemic therapy for operable breast cancer: equivalent outcomes?
    Smith BL
    Ann Surg; 2013 Feb; 257(2):180-1. PubMed ID: 23291659
    [No Abstract]   [Full Text] [Related]  

  • 14. Medical treatment of early breast cancer. IV: neoadjuvant treatment.
    Smith I; Chua S
    BMJ; 2006 Jan; 332(7535):223-4. PubMed ID: 16439402
    [No Abstract]   [Full Text] [Related]  

  • 15. Neoadjuvant chemotherapy for breast cancers: current recommendations and future directions.
    Andre F; Delaloge S
    Eur J Cancer; 2009 Sep; 45 Suppl 1():368-70. PubMed ID: 19775634
    [No Abstract]   [Full Text] [Related]  

  • 16. Neoadjuvant Systemic Therapy Use for Younger Patients with Breast Cancer Treated in Different Types of Cancer Centers Across the United States.
    Mohiuddin JJ; Deal AM; Carey LA; Lund JL; Baker BR; Zagar TM; Jones EL; Marks LB; Chen RC
    J Am Coll Surg; 2016 Nov; 223(5):717-728.e4. PubMed ID: 27788894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoadjuvant versus adjuvant systemic treatment in breast cancer: a meta-analysis.
    Mauri D; Pavlidis N; Ioannidis JP
    J Natl Cancer Inst; 2005 Feb; 97(3):188-94. PubMed ID: 15687361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The timing of breast and axillary surgery after neoadjuvant chemotherapy for breast cancer.
    Al-Hilli Z; Boughey JC
    Chin Clin Oncol; 2016 Jun; 5(3):37. PubMed ID: 27164853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast conservation after neoadjuvant chemotherapy.
    Sadetzki S; Oberman B; Zipple D; Kaufman B; Rizel S; Novikov I; Papa MZ
    Ann Surg Oncol; 2005 Jun; 12(6):480-7. PubMed ID: 15868065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary systemic chemotherapy for inflammatory breast cancer.
    Sinclair S; Swain SM
    Cancer; 2010 Jun; 116(11 Suppl):2821-8. PubMed ID: 20503414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.